PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Advanced Drug Delivery, Pharmaceutical Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, CB21 6GH, UK.\', \'University of Michigan Medical School, Department of Molecular & Integrative Physiology, Ann Arbor, MI, 48109-5624, USA.\', \'Advanced Drug Delivery, Pharmaceutical Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, 43183, Sweden.\', \'Bioscience Renal, Research and Early Development, Cardiovascular, Renal & Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Cambridge, CB21 6GH, UK.\', \'Rutherford Appleton Laboratory, ISIS Facility, Science and Technology Facilities Council, Didcot, OX11 0QX, UK.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1002/smll.202105832
?:doi
?:hasPublicationType
?:journal
  • Small (Weinheim an der Bergstrasse, Germany)
is ?:pmid of
?:pmid
?:pmid
  • 34914866
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Mechanistic Studies of an Automated Lipid Nanoparticle Reveal Critical Pharmaceutical Properties Associated with Enhanced mRNA Functional Delivery In Vitro and In Vivo.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34914866>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34914866>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all